COVID Update: Scripps provides COVID-19 tests only for patients with moderate to severe symptoms, and at-risk patients with mild symptoms. Read our FAQs.
CareWare light 'patch' therapy for the treatment of acne vulgaris
E. Victor Ross, M.D.
This study is evaluating the effectiveness of combined blue and red light therapy as an “at home” treatment for moderate acne using wearable CareWare light patches. Study duration is about 6 weeks. Visits may be done in the clinic or by virtual/video visit.
Be 18 – 35 years of age
Have a clinical diagnosis of moderate acne vulgaris
Have at least 20 inflammatory lesions
Be willing to avoid excess sun exposure and not use topical or oral anti-acne medications including medicated shampoo or soap during the study period
Meet all other eligibility criteria
Patients must not:
Have used oral retinoid therapy such as isotretinoin within the past 12 months
Have a diagnosis of psoriasis, seborrheic dermatitis or papulopustular rosacea
Have a history of keloids
Have an active infection
Have tattoos or excess scarring in the treatment areas
Be pregnant or planning to become pregnant, lactating, or nursing
CareWear light patches are wearable “stick and go” patches that are reusable and flexible. The patch uses patented LED light technology connected to a waterproof, rechargeable wireless controller that delivers a pre-programmed dosage of light.